Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: Focus on romiplostim and eltrombopag

Medicine & Life Sciences

• romiplostim 100%
• eltrombopag 97%
• Idiopathic Thrombocytopenic Purpura 70%
• Platelet Count 56%
• Placebos 17%
• Blood Platelets 13%
• Danazol 11%
• Spontaneous Remission 11%
• Thrombopoietin 11%
• Dapsone 11%
• Drug Approval 10%
• Pharmaceutical Preparations 10%
• Therapeutics 9%
• Dosage Forms 9%
• Azathioprine 9%
• Rituximab 9%
• Combination Drug Therapy 8%
• United States Food and Drug Administration 8%
• Patient Compliance 8%
• Cyclosporine 7%
• Drug-Related Side Effects and Adverse Reactions 7%
• Appointments and Schedules 6%
• Chronic Disease 6%
• Safety 4%
• Injections 4%